Accelerated Integration of Scarce Medical Service Resources in China's First-Tier Cities
BioMérieux accelerates the development of molecular diagnostics business in China.
Committed to becoming the world's largest production base of culture media and an international leading CDMO platform.
Possesses the core advantages of "brand + technology + internationalization + fashion."
This round of financing will be used to further accelerate key industrial layout and build an AI-based enterprise ecosystem.
Synthetic Bio
Chronicle of Major Events on the GLP Track in 2024
Synthetic Bio
Research on the Sweetener Industry